SALL4 and colorectal carcinoma: In contrast to the above studies, one study showed negative expression of SALL4 in 20 cases of AFP-producing colorectal cancer (Ren et al. 2019), which indicates that the use of SALL4 as a biomarker in this type of CRC needs to be further validated.